ID: ALA3984832

Max Phase: Preclinical

Molecular Formula: C17H17ClN2O2S

Molecular Weight: 348.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1N(C(=O)CSc1ncccc1Cl)CCC2

Standard InChI:  InChI=1S/C17H17ClN2O2S/c1-22-14-8-2-5-12-6-4-10-20(16(12)14)15(21)11-23-17-13(18)7-3-9-19-17/h2-3,5,7-9H,4,6,10-11H2,1H3

Standard InChI Key:  RCQANPHBEVONMT-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily V member 3 542 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.86Molecular Weight (Monoisotopic): 348.0699AlogP: 3.82#Rotatable Bonds: 4
Polar Surface Area: 42.43Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.81CX LogP: 3.37CX LogD: 3.37
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.79Np Likeness Score: -1.69

References

1.  (2015)  Compounds of modulating TRPV3 function, 

Source

Source(1):